The neuronal ceroid lipofuscinoses (a.k.a. Batten Disease) are a group of progressive neurodegenerative disorders of childhood characterized by blindness and gray matter deterioration. Behavioral and psychiatric disturbances frequently complicate the clinical course. They are of particular interest because they are relatively common (among the childhood hereditary disorders) and because of the resemblance of the characteristic autofluorescent storage material to aging pigment (lipofuscin). Recently, as many as eight genes have been implicated in various forms of the disorder. In this News & Commentary, the known functions and properties of these genes are discussed. The view is put forth that the NCLs (neuronal ceroid lipofuscinosis) represent further examples of abnormal protein accumulation causing neurodegeneration. In this case, the abnormal storage occurs in the lysosome as a result of deficient protease activity or defects in related enzymes. Recent mouse models of the NCLs are also discussed.
PERSPECTIVE Is Tourette's syndrome an autoimmune disease? PJ Hoekstra, CGM Kallenberg, J Korf, RB Minderaa
Once thought as having a psychogenic cause, Tourette's syndrome (TS, characterized by the presence of both motor and vocal tics) is now generally regarded as a neurobiological disorder with a genetic background. Recent research data suggest the involvement of autoimmune mechanisms occurring in the aftermath of streptococcal infections. In susceptible individuals, antibodies are thought to cross-react with brain structures, possibly causing tics and associated features. A comprehensive overview is given of evidence supporting the involvement of autoimmunity, including implications for immunomodulatory treatment application.
SCIENTIFIC CORRESPONDENCE
Family-based association studies of COMT gene polymorphisms and schizophrenia in Chinese population JB Fan, WY Chen, JX Tang, S Li, NF Gu, GY Feng, G Breen, D St Clair, L He Recently, significant association between Catechol-Omethyltransferase (COMT) and schizophrenia has been reported and a possible mechanism of how COMT variation increases risk for schizophrenia has been suggested. The authors tested the transmission of five SNP markers in COMT gene region from parents to schizophrenic offspring in 166 Chinese family trios. Their data suggest that the COMT gene is not likely to play a major role in the aetiology of schizophrenia in the Chinese population.
Identification of a single nucleotide polymorphism at the 5Ј promoter region of human reelin gene and association study with schizophrenia
M-L Chen, S-Y Chen, C-H Huang, C-H Chen
Reelin protein is essential for embryonic brain development. Recent studies indicated that reelin might be a vulnerability factor for schizophrenia. The authors hypothesized that functional polymorphism at the 5Ј promoter region of the human reelin gene might confer genetic susceptibility to some schizophrenic patients. They identified a G/C single nucleotide polymorphism (SNP) at 5Ј promoter region of reelin gene (designated g.-888GϾC). This SNP could alter the Sp1 and/or hsp70.2 transcription factor binding sites by computer analysis. However, a case-control association study did not support the association of this SNP with schizophrenic patients in this patient cohort.
Epistatic effect of genes from the dopamine and serotonin systems on the temperament traits of Novelty Seeking and Harm Avoidance S Van Gestel, T Forsgren, S Claes, J Del-Favero, CM van Duijn, S Sluijs, L-G Nilsson, R Adolfsson, C Van Broeckhoven
The authors analyzed whether genes involved in the dopaminergic and serotonergic systems could influence temperament dimensions. They used in their study extreme scoring individuals on the temperament dimensions Novelty Seeking and Harm Avoidance, derived from a northern Swedish population-based study. The authors found positive associations between the dopamine transporter gene and novelty seeking, and between the serotonin transporter gene and harm avoidance. The genetic associations were strongest in females. Also, the associations seemed modulated by the presence or absence of the 7-repeat allele of the dopamine D4 receptor gene, suggestive for epistatic effects.
Association analysis of adenylate cyclase type 9 gene using pedigree disequilibrium test in bipolar disorder T Toyota, K Yamada, K Saito, SD Detera-Wadleigh, T Yoshikawa
Chromosome 16 short arm has been shown to display modest linkage for mood disorders. The authors investigated the potential role of ADCY9 which maps to 16p13.3. Among 11 polymorphisms detected, they selected the missense Ile772Met and (TTTA)n for genetic evaluation. Analysis of the NIMH Genetics Initiative bipolar pedigrees by using the pedigree disequilibrium test revealed an evidence of association for both variants, warranting further study.
IMMEDIATE COMMUNICATION Bipolar disorder susceptibility region on Xq24-q27.1 in Finnish families JM Ekholm, P Pekkarinen, P Pajukanta, T Kieseppä , T Partonen, T Paunio, T Varilo, M Perola, J Lö nnqvist, L Peltonen
Some of the strongest linkage findings in bipolar disorder (BPD) have been observed in large pedigrees, most probably revealing the effect of a relatively rare gene, enriched in these pedigrees. The authors have earlier reported significant evidence of linkage for BPD to chromosome Xq24-q27.1 in an extended pedigree from the late settlement region of the genetically isolated population of Finland. Here they tested linkage of this particular chromosomal region in 40 multiplex BPD families collected from the whole of Finland and showed that only a fraction of families provided any evidence for linkage. However, the genome-wide scan performed in the original pedigree revealed the best evidence for linkage to this X-chromosomal region, supporting its major role in the genetic background of BPD of this family also at the genome-wide level.
ORIGINAL RESEARCH ARTICLES
D2S2944 identifies a likely susceptibility locus for recurrent, early-onset, major depression in women GS Zubenko, HB Hughes III, JS Stiffler, WN Zubenko, BB Kaplan Recurrent, Early-onset, Major Depressive Disorder (RE-MDD) is a strongly familial condition that impairs health and longevity. Sixteen of 19 candidate susceptibility loci identified by a recent genome survey revealed allelic associations with RE-MDD in men or women, but not in both sexes. Women who carried the D2S2944 124-bp allele revealed a significantly elevated Molecular Psychiatry risk of developing RE-MDD, as indicated by an odds ratio of 4.5 compared to female controls (P Ͻ 0.001). In contrast, men who were carriers did not exhibit an increased risk of developing RE-MDD or related disorders. The D2S2944 124-bp allele also appeared to increase the risk of Alcohol and Other Substance Use Disorders among women with RE-MDD. The transmission/disequilibrium test provided confirmatory evidence of these sex-specific findings within families. These results suggest that there may be important differences in the molecular basis of clinical depression in men and women, or sex-specific differences in the molecular mechanisms that determine resistance to depressive stimuli.
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy L Capuron, A Ravaud, PJ Neveu, AH Miller, M Maes, R Dantzer
Cytokine therapy induces depressive symptoms by unknown mechanisms. This study assessed the relationship between serum concentrations of the amino acids tryptophan and tyrosine and depressive symptoms in 16 cancer patients undergoing Interleukin-2 and/or IFN-␣ therapy. Tryptophan concentrations significantly decreased during the first month of therapy. These decreases were associated with the development and severity of depressive symptoms, especially pessimism, suicidal ideation, distractibility and anorexia. These findings suggest that reduced availability of tryptophan mediates the development of depressive symptoms during cytokine therapy. KE Gabry, GP Chrousos, KC Rice, RM Mostafa, E Sternberg, AB Negrao, EL Webster, SM McCann, PW Gold Stress precipitates gut dysfunction in most species. Corticotropin-releasing hormone (CRH) has been shown to mediate behavioral, autonomic and endocrine responses to stress in rodents and nonhuman primates. In this article, the authors document that endogenous CRH, via CRH type-1 receptor (CRH-R1), mediates gastric ulceration and colonic dysfunction in response to severe stress in rats. They utilized the novel nonpeptide CRH-R1 antagonist, antalarmin, to address this topic. The authors suggest that nonpeptide CRH antagonists may be therapeutic for stress-related gastrointestinal disorders such as peptic ulcer and irritable bowel syndrome. to study complexin I and complexin II in postmortem brain tissue from cases of schizophrenia, depression with suicide and controls. Complexin I was reduced in both mental illnesses, complexin II was unchanged. The complexin I : complexin II balance was significantly altered. Antipsychotic drugs did not affect complexin proteins in rats. Abnormalities of complexin I are present in severe mental disorders, and could result in abnormalities of neurotransmission.
Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs
Characterization, mutation detection, and association analysis of alternative promoters and 5ЈUTRs of the human dopamine D3 receptor gene in schizophrenia RJ Anney, MI Rees, E Bryan, G Spurlock, N Williams, N Norton, H Williams, A Cardno, S Zammit, S Jones, G Jones, B Hoogendoorn, K Smith, ML Hamshere, S Coleman, C Guy, MC O'Donovan, MJ Owen, PR Buckland The dopamine D3 receptor gene (DRD3) is a candidate for a number of psychiatric conditions and previous studies have reported associations between polymorphisms in DRD3 and these disorders. The authors have used 5Ј RACE to identify three hitherto unknown upstream exons (non-coding) and two putative promoters within a 9-kb genomic region. A number of novel polymorphisms were identified but no associations were observed with schizophrenia.
Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism S-J Kim, LJ Young, D Gonen, J Veenstra-VanderWeele, R Courchesne, E Courchesne, C Lord, BL Leventhal, EH Cook Jr, TR Insel In animal studies, the hormone, arginine vasopressin (AVP), has been shown to increase a range of social behaviors, including affiliation and attachment, via the V 1a receptor in the brain. Nominally significant transmission disequilibrium was found with one AVPR1A microsatellite marker that did not withstand Bonferroni correction for the two markers studied. Direct sequencing revealed several polymorphisms that may be useful in study of this gene in autism and other disorders and social qualitative traits.
Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate receptor NM Williams, T Bowen, G Spurlock, N Norton, HJ Williams, B Hoogendoorn, MJ Owen, MC O'Donovan The glutamatergic N-methyl D-aspartate receptors (NMDA) system has been implicated in many neuropsychiatric disorders including learning and learning disability, memory, epilepsy, CNS recovery after trauma or ischaemia, neurodegenerative diseases, schizophrenia, affective disorder, and alcohol dependence. As many of these disorders have a genetic basis, the authors sought to identify DNA sequence variants in all NMDA receptors. Although 27 variants were found, the results suggest that these genes are under intense pressure to conserve their structure. The very low rate of variation that changes amino acids also suggests that it is very unlikely that the DNA mutation altering protein structure plays a major role in any common neuropsychiatric phenotypes, and in particular schizophrenia.
CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia H Ujike, M Takaki, K Nakata, Y Tanaka, T Takeda, M Kodama, Y Fujiwara, A Sakai, S Kuroda
Overactivation of the endogenous cannabinoid system has been supposed for possible pathogenesis of schizophrenia based on clinical findings that chronic marijuana use often produces a psychotic state resembling that of schizophrenia. This article examines genetic association between the polymorphisms of the CNR1 gene, which encodes a subclass of central cannabinoid receptors. Although the polymorphism 1359G/A was not associated with schizophrenia, the AAT triplet repeat polymorphism in 3Ј flanking region of the CNR1 gene was significantly associated with schizophrenia, especially the hebephrenic subtype. This finding strongly supports the genetically cannabinoid hypothesis for schizophrenia.
